Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Reviewing colorectal cancer from an anthropological lens.
Researchers are investigating AI’s potential to transform cancer care and improve patient outcomes.
The ENLACE team includes bilingual genetic counselors who are trained in culturally sensitive ways of communicating genetic information.
70% of breast cancer patients in rural settings changed their cancer care plans based on genetic test results.
For the research team, the question was: “Can we turn something that is good for the cancer into something that will kill [it]?”
There are a number of factors that may contribute to the rising risk of CRC in young adults.
Understanding how this variant helped people fend off the virus could lead to better ways to protect against COVID.
Learn more about melanoma risk factors, hereditary melanoma, and genetic testing.
Inherited genetic determinants can cause normal variations in PSA levels even in the absence of prostate cancer
Common and cheap epilepsy drug stops tumor growth in mice
Research shows that colorectal cancer patients with African ancestry had shorter survival and fewer mutations needed for immunotherapy.
Individuals would better understand their personal cancer risks for multiple cancers, make informed decisions
CU Cancer Center researchers spotlight how p53, the most frequently mutated tumor suppressor gene, can be activated against cancer cells.
Some people have inherited genetic syndromes that increase their risk for colon cancer.
Researchers found a new gene, ZFP36L1, that hasn’t been studied in association with small-cell lung cancer and the protein LSD1.
Study finds that risk of adverse side effects from cancer immunotherapy is higher in patients with certain inherited genetic variations.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.